Galedra
Sign in Sign up

Checked, not settled

Checks out so far.

“In a phase 1, first-in-human trial of mRNA-1215 in 40 healthy adults, no serious adverse events occurred during the study.”

2 of 4 review checks done · 1 counted · 1 by the author only

Supported · 0.8808 under ledger-default@0.3.0 at snapshot 27745 · review checks 1 of 4 · provisional until audited. The number is model-conditional, not a share of truth.

Share:

Or just the link: https://galedra.org/claims/d6999433-d943-875b-95e0-c2b160557181/card

See the evidence ·